Sign up to save your podcasts
Or
Share Covid-19: USFDA approves remdesivir
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Covid-19: USFDA approves remdesivir
The US Food and Drug Administration has approved Gilead Sciences’ anti-viral remdesivir, making it the first treatment for Covid-19 to get the final go-ahead from the regulator. Veklury was approved for use in adult and pediatric patients aged 12 and higher, says USFDA.
Listen to the podcast.
Click here for more details.
---
Send in a voice message: https://anchor.fm/business-line/message
View all episodes
By BusinessLineThe US Food and Drug Administration has approved Gilead Sciences’ anti-viral remdesivir, making it the first treatment for Covid-19 to get the final go-ahead from the regulator. Veklury was approved for use in adult and pediatric patients aged 12 and higher, says USFDA.
Listen to the podcast.
Click here for more details.
---
Send in a voice message: https://anchor.fm/business-line/message
More shows like BusinessLine Podcasts
View all
Economist Podcasts
4,225 Listeners
WSJ Your Money Briefing
1,713 Listeners
World Business Report
296 Listeners
WSJ Tech News Briefing
1,649 Listeners
Moneycontrol Podcast
14 Listeners
3 Things
57 Listeners
FT News Briefing
684 Listeners
The Intelligence from The Economist
2,592 Listeners
The World in Brief from The Economist
1,089 Listeners
ThePrint
89 Listeners
Finshots Daily
40 Listeners
Top of the Morning
5 Listeners
The Morning Brief
15 Listeners
Daybreak
11 Listeners
The Daily Brief
10 Listeners